Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer.
about
Quality of life in the trastuzumab for gastric cancer trialRole of lapatinib alone or in combination in the treatment of HER2-positive breast cancerQuality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer.Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer.Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.A comparison of quality of life of early breast cancer patients treated with accelerated partial breast irradiation versus whole breast irradiation in China.
P2860
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Quality-of-life and quality-ad ...... for metastatic breast cancer.
@en
type
label
Quality-of-life and quality-ad ...... for metastatic breast cancer.
@en
prefLabel
Quality-of-life and quality-ad ...... for metastatic breast cancer.
@en
P2093
P1476
Quality-of-life and quality-ad ...... for metastatic breast cancer.
@en
P2093
Angelo Di Leo
Beth Sherrill
Henry L Gomez
Jose Bines
Mayur M Amonkar
Zanete Zvirbule
P304
P356
10.1185/03007991003590860
P407
P577
2010-04-01T00:00:00Z